Jun 2026 (Q2 FY26) — Aug 6, 2026
Arteris, Inc. Q2 FY26 — Record ACV, Revenue, and RPO with Raised Full-Year Outlook
Read the full callArteris (AIP) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Arteris earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 24.1 | +46.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -57.6 | −7.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -14.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$19.92 +1.27% · +$0.25
Performance +48.7% 1Y
1Y: $13.4 on 14 Oct 2025 → $19.92. High $48.59 (30 Jun 2026), low $12.32 (4 Nov 2025).
- Previous close
- $19.67
- 52-week range
- $12.32 – $48.59
- One year
- +38.24%
Overview
- Symbol
- AIP
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Arteris earnings calls (AIP)
Financials
What the filings say
Net profit, year on year: −54% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 15 | 15 | 17 | 17 | 17 | 20 | 23 | 24 |
| Operating profit | -8 | -7 | -8 | -8 | -9 | -8 | -9 | -14 |
| Operating margin | −53.8% | −45.9% | −46.6% | −50.0% | −50.1% | −42.0% | −40.5% | −57.6% |
| Other income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -7 | -6 | -7 | -8 | -8 | -8 | -9 | -13 |
| Tax rate | 1.3% | −19.7% | −3.8% | −11.3% | −4.7% | 0.2% | 42.7% | −5.2% |
| Net profit | -8 | -8 | -8 | -9 | -9 | -9 | -8 | -14 |
| EPS ($ per share) | -0.20 | — | -0.20 | -0.22 | -0.21 | — | -0.17 | -0.30 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -16 | -39 | -66 | -103 | -137 | -172 |
| Total liabilities | 49 | 68 | 78 | 88 | 107 | 130 |
| Fixed assets | 2 | 2 | 4 | 6 | 4 | 4 |
| Investments | — | — | 31 | 27 | 30 | — |
| Total assets | 43 | 120 | 116 | 103 | 106 | 115 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | 2 | -1 | -7 | -16 | -1 | 7 |
| Cash from investing | -5 | -1 | -37 | -5 | 1 | 12 |
| Cash from financing | 1 | 76 | -4 | -3 | -0 | 1 |
| Net cash flow | -2 | 74 | -48 | -23 | -0 | 20 |
| Capital expenditure | -1 | -1 | -1 | -2 | -0 | -1 |
| Free cash flow | 2 | -2 | -8 | -17 | -1 | 5 |
Insider filings
269 filings between Nov 3, 2025 and Oct 5, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$120.32M
223 sales by 9 insiders
83% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 18
- Award — granted as compensation
- 18
- Option exercise — converted options into shares
Also filed: 10 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| JANAC K CHARLES | — | $42.32M | Oct 5, 2026 |
| Bayview Legacy, LLC | — | $40.27M | Oct 1, 2026 |
| RAZA SAIYED ATIQ | — | $16.59M | Aug 3, 2026 |
| Hawkins Nicholas B. | — | $8.28M | Aug 13, 2026 |
| Moll Laurent R | — | $4.56M | Oct 5, 2026 |
| Viana Antonio J | — | $4.13M | Jun 4, 2026 |
| Alpern Paul L | — | $2.35M | Oct 5, 2026 |
| Cantwell Wayne C | — | $1.43M | May 26, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 6,003 | $145.5K |
| Oct 5, 2026 | Kunkel Joachim Director | Award | 633 | $0 |
| Oct 5, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 12,219 | $296.8K |
| Oct 5, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 11,452 | $278.0K |
| Oct 5, 2026 | Munce Claudia F. Director | Award | 605 | $0 |
| Oct 2, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 1,889 | $46.6K |
| Oct 2, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 887 | $21.9K |
| Oct 2, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 893 | $22.0K |
| Oct 2, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 1,931 | $47.6K |
| Oct 2, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 765 | $18.9K |
| Oct 2, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 2,775 | $68.4K |
| Oct 2, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 1,966 | $48.4K |
| Oct 2, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 692 | $17.1K |
| Oct 2, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 1,181 | $29.1K |
| Oct 2, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 1,843 | $45.4K |
| Oct 2, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 1,010 | $24.9K |
| Oct 2, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 2,775 | $68.4K |
| Oct 1, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 6,500 | $154.9K |
| Oct 1, 2026 | Alpern Paul L VP and General Counsel | Option exercise 10b5-1 plan | 2,500 | $23.2K |
| Oct 1, 2026 | Alpern Paul L VP and General Counsel | Option exercise 10b5-1 plan | 4,000 | $2.2K |
| Oct 1, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 100,000 | $2.38M |
| Oct 1, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 100,000 | $2.38M |
| Sep 14, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 100 | $2.2K |
| Sep 14, 2026 | Moll Laurent R Chief Operating Officer | Sale 10b5-1 plan | 9,119 | $190.0K |
| Sep 8, 2026 | Sinha Saurabh Chief Financial Officer | Award | 142,835 | $0 |
| Sep 1, 2026 | Alpern Paul L VP and General Counsel | Option exercise 10b5-1 plan | 4,000 | $2.2K |
| Sep 1, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 4,000 | $83.1K |
| Sep 1, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 100,000 | $2.07M |
| Sep 1, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 100,000 | $2.07M |
| Sep 1, 2026 | Cantwell Wayne C Director | Gift | 5,000 | $0 |
| Sep 1, 2026 | Cantwell Wayne C Director | Gift | 5,000 | $0 |
| Aug 28, 2026 | Cantwell Wayne C Director | Option exercise | 5,000 | $3.0K |
| Aug 13, 2026 | Hawkins Nicholas B. VP and Chief Financial Officer | Sale | 10,431 | $294.8K |
| Aug 13, 2026 | Hawkins Nicholas B. VP and Chief Financial Officer | Option exercise | 3,125 | $29.0K |
| Aug 12, 2026 | Hawkins Nicholas B. VP and Chief Financial Officer | Sale | 200 | $5.8K |
| Aug 4, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 2,600 | $84.3K |
| Aug 4, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 2,600 | $84.3K |
| Aug 4, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 23,506 | $750.4K |
| Aug 4, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 23,506 | $750.4K |
| Aug 3, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 6,321 | $182.0K |
| Aug 3, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 25,158 | $762.6K |
| Aug 3, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 3,400 | $102.7K |
| Aug 3, 2026 | Alpern Paul L VP and General Counsel | Sale 10b5-1 plan | 600 | $17.5K |
| Aug 3, 2026 | RAZA SAIYED ATIQ Director | Sale 10b5-1 plan | 27,252 | $825.8K |
| Aug 3, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 42,415 | $1.27M |
| Aug 3, 2026 | Alpern Paul L VP and General Counsel | Option exercise 10b5-1 plan | 4,000 | $2.2K |
| Aug 3, 2026 | RAZA SAIYED ATIQ Director | Sale 10b5-1 plan | 36,827 | $1.10M |
| Aug 3, 2026 | RAZA SAIYED ATIQ Director | Sale 10b5-1 plan | 5,921 | $170.4K |
| Aug 3, 2026 | JANAC K CHARLES President and CEO | Sale 10b5-1 plan | 6,321 | $182.0K |
| Aug 3, 2026 | Bayview Legacy, LLC 10% owner | Sale 10b5-1 plan | 25,158 | $762.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Arteris, Inc.
Free account. Everything above stays public.
Write why you follow Arteris, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading